AstraZeneca beat analysts’ estimates with 18 per cent growth in revenue in the first quarter of 2024, driven by stronger sales of its cancer drugs. The UK-based pharmaceutical group reported revenue ...
The conservative-leaning National Legal and Policy Center criticized Goldman Sachs CEO David Solomon's leadership at the bank ...
In a recent Instagram post, he said "I'm in the process of designing a long-term chain.” A few days back, Mark Zuckerberg ...
Shreyas Patil; Research Analyst; Wolfe Research, LLC ...
Saul Martinez; Senior US Financials Analyst; HSBC, Research Division ...